Early Effects of Triamcinolone on Vascular Endothelial Growth Factor and Endostatin in Human Choroidal Neovascularization
Tatar et al.
Arch Ophthalmol 2008;126:193-199.
ABSTRACT
| FULL TEXT
Angiogenesis Inhibition and Choroidal Neovascularization Suppression by Sustained Delivery of an Integrin Antagonist, EMD478761
Fu et al.
IOVS 2007;48:5184-5190.
ABSTRACT
| FULL TEXT
Positive Feedback Regulation between MMP-9 and VEGF in Human RPE Cells
Hollborn et al.
IOVS 2007;48:4360-4367.
ABSTRACT
| FULL TEXT
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study
Chan et al.
Br. J. Ophthalmol. 2007;91:174-179.
ABSTRACT
| FULL TEXT
Perspectives on verteporfin therapy combined with intravitreal corticosteroids.
Schmidt-Erfurth et al.
Arch Ophthalmol 2006;124:561-563.
FULL TEXT
Should corticosteroids be considered as part of the standard care with photodynamic therapy?
Zarbin
Arch Ophthalmol 2006;124:563-571.
FULL TEXT
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
Chan et al.
Br. J. Ophthalmol. 2006;90:337-341.
ABSTRACT
| FULL TEXT
Toxicity of Triamcinolone Acetonide on Retinal Neurosensory and Pigment Epithelial Cells
Narayanan et al.
IOVS 2006;47:722-728.
ABSTRACT
| FULL TEXT
Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo
Spandau et al.
Br. J. Ophthalmol. 2005;89:745-747.
ABSTRACT
| FULL TEXT
Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration
Jonas et al.
Br. J. Ophthalmol. 2004;88:1557-1562.
ABSTRACT
| FULL TEXT
Trans-Tenon's retrobulbar triamcinolone infusion for small choroidal neovascularisation
Okada et al.
Br. J. Ophthalmol. 2004;88:1097-1098.
FULL TEXT
Safety of an Intravitreal Injection of Triamcinolone: Results From a Randomized Clinical Trial
Gillies et al.
Arch Ophthalmol 2004;122:336-340.
ABSTRACT
| FULL TEXT
The Squirrel Monkey: Characterization of a New-World Primate Model of Experimental Choroidal Neovascularization and Comparison with the Macaque
Criswell et al.
IOVS 2004;45:625-634.
ABSTRACT
| FULL TEXT
Noninfectious Endophthalmitis Associated With Intravitreal Triamcinolone Injection
Roth et al.
Arch Ophthalmol 2003;121:1279-1282.
ABSTRACT
| FULL TEXT
Macrophage Depletion Diminishes Lesion Size and Severity in Experimental Choroidal Neovascularization
Espinosa-Heidmann et al.
IOVS 2003;44:3586-3592.
ABSTRACT
| FULL TEXT
Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants
Ciulla et al.
Br. J. Ophthalmol. 2003;87:1032-1037.
ABSTRACT
| FULL TEXT
A Randomized Clinical Trial of a Single Dose of Intravitreal Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration: One-Year Results
Gillies et al.
Arch Ophthalmol 2003;121:667-673.
ABSTRACT
| FULL TEXT
Intravitreal triamcinolone acetonide for exudative age related macular degeneration
Jonas et al.
Br. J. Ophthalmol. 2003;87:462-468.
ABSTRACT
| FULL TEXT
Intraocular pressure after intravitreal injection of triamcinolone acetonide
Jonas et al.
Br. J. Ophthalmol. 2003;87:24-27.
ABSTRACT
| FULL TEXT
Modulation of Permeability and Adhesion Molecule Expression by Human Choroidal Endothelial Cells
Penfold et al.
IOVS 2002;43:3125-3130.
ABSTRACT
| FULL TEXT
Intravitreal triamcinolone in recurrence of choroidal neovascularisation
Penfold
Br. J. Ophthalmol. 2002;86:600-601.
FULL TEXT